Global Endometriosis Treatment Market Size (2024 - 2029)

Global Endometriosis Treatment Market Analysis

The Global Endometriosis Treatment Market size is estimated at USD 1.58 billion in 2024, and is expected to reach USD 2.80 billion by 2029, growing at a CAGR of 12.07% during the forecast period (2024-2029).

Endometriosis is the uterine pain that can be life-threatening if not treated properly. The surging burden of endometriosis and disorders like ovarian disorders and menstrual diseases are the major factors projected to drive the endometriosis treatment market. In addition, increased efforts to develop advanced approaches to manage endometriosis and favorable government legislation are supporting market expansion.

According to a March 2023 update by the World Health Organization, approximately 10% (190 million) of women and girls of childbearing age worldwide were affected by endometriosis. The condition is common in females and can start at a person’s first menstrual period and last until menopause. Moreover, according to December 2023 data from Endometriosis UK, the condition is common across the United Kingdom and affects 1 in every 10 women. Thus, the high burden of endometriosis among women is expected to accelerate market growth over the forecast period.

In addition, increasing awareness of the disease and the growing need for early detection are among the major factors driving the market's growth. For instance, Endometriosis Association Inc. is one of the leading non-profit organizations that provides support to women suffering from endometriosis and creates awareness about the condition. Moreover, the organization provides funds and grants to universities and research institutes to discover breakthrough therapies for endometriosis. Thus, such initiatives are anticipated to propel the endometriosis treatment market over the coming years.

Additionally, increased funding and grants from various government and non-government organizations to support endometriosis research are boosting the market’s growth. For instance, in March 2023, researchers at the University of Edinburgh, Aberdeen, and Birmingham received USD 3,00,000 in funding from the Wellbeing of Women and the Scottish government to investigate the efficiency of dichloroacetate in treating endometriosis. In addition, in September 2023, Endometriosis New Zealand granted a research fund to advance the understanding of various treatment approaches to treat endometriosis. This research aimed to investigate various approaches that can be crucial to manage this life-threatening condition. Thus, such funding and grants are anticipated to propel the market’s growth over the forecast period.

Though the abovementioned factors are anticipated to boost the market’s growth over the forecast period, the high cost of endometriosis treatment will likely impede this growth.

Global Endometriosis Treatment Industry Segmentation

As per the scope of the report, endometriosis is a medical condition in which tissues similar to the endometrium grow in ovaries and fallopian tubes. It can affect women of all ages, including teenagers, and cause pain or infertility. The endometriosis treatment market is segmented by type, treatment type, end user, and geography. By type, the market is segmented into superficial peritoneal endometriosis, endometriomas, deeply infiltrating endometriosis, and other types. By treatment type, the market is segmented into pain medication and hormone therapy. By end user, the market is segmented into hospitals, specialty clinics, and other end users. The report also covers the market sizes and forecasts for the endometriosis treatment market in major countries across different regions. For each segment, the market size is provided in terms of value (USD).